152 related articles for article (PubMed ID: 18521441)
41. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
42. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
43. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
44. Soluble EMMPRIN (extra-cellular matrix metalloproteinase inducer) stimulates the migration of HEp-2 human laryngeal carcinoma cells, accompanied by increased MMP-2 production in fibroblasts.
Hanata K; Yamaguchi N; Yoshikawa K; Mezaki Y; Miura M; Suzuki S; Senoo H; Ishikawa K
Arch Histol Cytol; 2007 Dec; 70(5):267-77. PubMed ID: 18431027
[TBL] [Abstract][Full Text] [Related]
45. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
46. The role of extracellular matrix metalloproteinase inducer (EMMPRIN) in the regulation of bovine endometrial cell functions.
Mishra B; Kizaki K; Sato T; Ito A; Hashizume K
Biol Reprod; 2012 Jun; 87(6):149. PubMed ID: 23115270
[TBL] [Abstract][Full Text] [Related]
47. Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas.
Kjellman M; Enberg U; Höög A; Larsson C; Holst M; Farnebo LO; Sato H; Bäckdahl M
World J Surg; 1999 Mar; 23(3):237-42. PubMed ID: 9933692
[TBL] [Abstract][Full Text] [Related]
48. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
49. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
[TBL] [Abstract][Full Text] [Related]
50. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
[TBL] [Abstract][Full Text] [Related]
51. Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease.
Musiał K; Bargenda A; Zwolińska D
Ren Fail; 2015 Jul; 37(6):980-4. PubMed ID: 25945606
[TBL] [Abstract][Full Text] [Related]
52. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
[TBL] [Abstract][Full Text] [Related]
53. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction.
Gabison EE; Mourah S; Steinfels E; Yan L; Hoang-Xuan T; Watsky MA; De Wever B; Calvo F; Mauviel A; Menashi S
Am J Pathol; 2005 Jan; 166(1):209-19. PubMed ID: 15632013
[TBL] [Abstract][Full Text] [Related]
55. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
56. Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cδ/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages.
Wang Y; Huang ZQ; Wang CQ; Wang LS; Meng S; Zhang YC; Chen T; Fan YQ
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):11-8. PubMed ID: 21039753
[TBL] [Abstract][Full Text] [Related]
57. Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva.
Wang J; Yang D; Li C; Shang S; Xiang J
J Periodontal Res; 2014 Apr; 49(2):197-204. PubMed ID: 23647605
[TBL] [Abstract][Full Text] [Related]
58. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
59. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340).
Foda HD; Rollo EE; Drews M; Conner C; Appelt K; Shalinsky DR; Zucker S
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):717-24. PubMed ID: 11726397
[TBL] [Abstract][Full Text] [Related]
60. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
Madigan MC; Kingsley EA; Cozzi PJ; Delprado WJ; Russell PJ; Li Y
Cancer Immunol Immunother; 2008 Sep; 57(9):1367-79. PubMed ID: 18273614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
